Dechert to Defend GSK in Securities Class Action Over Alleged Link Between Zantac and Carcinogenic Compound
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...
BioSpace11h
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
Is magic suddenly happening to the dirt cheap GSK share price?
Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles, so can the FTSE ...
2 FTSE 100 stocks that investors should consider for income
Our writer Ken Hall evaluates two defensive dividend payers in the FTSE 100 that he thinks investors should consider buying ...
Investing Snacks4d
Bye-Bye, Band-Aids: Pfizer Wraps Up Haleon Exit
Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...
Business Insider5d
Shareholders that Lost Money on GSK plc (GSK) Should Contact Levi & Korsinsky about Pending Class Action - GSK
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the ...
Montreal Gazette5d
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
NeuroSense's Groundbreaking ALS Combination Therapy PrimeC Advances Towards commercialization in Canada; Potential for revenue in Canada alone of $100-150 million dollars. PrimeC Has Previously ...
3 steps to safeguard a Stocks and Shares ISA in 2025
This year's gearing up to be a wild ride for stocks and shares so investors should consider a careful approach to their ISA ...